Fluid biomarkers in Alzheimer's disease - current concepts
about
Current status of biomarker research in neurologyFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsRole of HIV in amyloid metabolismThe low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's diseaseThe potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressantsBiomarkers in dementia: clinical utility and new directionsComplex regulation of γ-secretase: from obligatory to modulatory subunitsGenetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunitiesA Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer DementiaBehavioral and psychological symptoms in Alzheimer's disease.Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease.Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease.Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse modelsThe γ-secretase complex: from structure to function.Idiopathic normal pressure hydrocephalus: cerebral perfusion measured with pCASL before and repeatedly after CSF removal.Blood amyloid beta levels in healthy, mild cognitive impairment and Alzheimer's disease individuals: replication of diastolic blood pressure correlations and analysis of critical covariates.Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampusThe elusive nature and diagnostics of misfolded Aβ oligomers.Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study.The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's diseaseThe cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease.An adaptive genetic algorithm for selection of blood-based biomarkers for prediction of Alzheimer's disease progressionLongitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementiaAntemortem Prediction of Braak Stage.Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical ResearchRaman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer's Disease.Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment.The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjectsReduced plasma desmosterol-to-cholesterol ratio and longitudinal cognitive decline in Alzheimer's disease.Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia.Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profileNo diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.
P2860
Q26744505-3B63CEBB-25E5-445C-B194-B377E6BA3356Q26784569-A2879867-0BC9-456C-BCE6-3505B162B0CFQ26824179-E2C13DB2-20F4-4F75-9F70-F6A1032C8479Q26827353-8A05CE11-CC0B-41C4-9191-9FF063907912Q26853347-62FE90C7-37C6-41FC-873A-E71CFF756BCBQ26996955-8051D8A0-5090-43C7-9204-D51465658BD5Q27007086-E68B2CAC-D477-4584-8A45-83399DFFE189Q28080576-8EDC0C9C-0F33-4E43-AEA3-D9C2D96A65FFQ28086879-C30AF25A-7D53-485B-BC03-1D51E00F4E6AQ30235315-04BAC7A7-7F91-4CC5-90F2-40F5A9974D18Q30996799-0692FB48-2F95-4782-B7EF-8F3D0CE78E11Q33801596-B516C762-930A-46A9-AE54-0BE61BF97666Q34009796-7A312445-B123-4F9F-8076-63891262E299Q34084101-F261268B-241D-499E-B764-4E99DCE25FAAQ34181135-F178EEE2-9181-4B3F-BDE2-74F2B59DF7D1Q34418781-50364D0C-F889-4027-946E-D99DA391B0D5Q34677532-9D964E6E-029B-4B20-9AD3-69BE99015BBBQ34727443-E918DD5B-822C-4C6F-B715-68A592AFB099Q35060510-1B0D37D4-DB6F-4528-AB0C-5965673DE4E0Q35085348-A7A99E96-4F34-456F-ACC7-843B709CF1D5Q35129501-9ECF0ADB-A31B-4A70-B535-CB210993000CQ35194588-DBCD2D67-1C94-4239-BD51-DF4408635B4CQ35669559-98C1D3C7-44BA-4F7A-A603-FA208FD54783Q35745168-BA79CA15-65C3-4693-82E3-327806A65552Q35750755-D68E31A0-E3FC-47B4-99F8-61D0C5E64B98Q35843380-E31D332F-8C47-4878-9328-C3DDA43A3703Q35848870-FCD4D05F-022D-42C8-B71F-9A162B9722E0Q35872357-8BFADC4A-728B-4D14-926B-CDB7A34B9A4CQ36062391-3172F25C-F58D-406E-8DD6-C27E4B17A7CDQ36074237-DDA5E168-0484-4AA9-B18E-0FB55447B568Q36175429-6FFA8E13-212D-429F-BFCB-83A97959685CQ36239384-FB9F4A94-19BA-4F2E-8751-7510CB2F6AE9Q36311817-FE32028F-0C2E-47C3-AEB8-D8D10C91AE7CQ36692487-AEFAD468-7BEE-45A0-9777-2326CBA0C91DQ36806654-590454FC-AAD0-4DD3-85DF-D607150A3CBCQ36926775-235523A5-E7AD-460F-B1B8-29D2ECDC01CEQ36933691-EAF13FE0-2374-4188-9B15-202C95FA48C7Q37049024-22BF5316-88F2-4D7D-AF6F-B0B1EA12B6D4Q37237233-E118C046-345F-4C81-93C7-98AE35FC8825Q37718557-3F9244A5-6935-4D86-B665-9E0F653F2013
P2860
Fluid biomarkers in Alzheimer's disease - current concepts
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Fluid biomarkers in Alzheimer's disease - current concepts
@en
type
label
Fluid biomarkers in Alzheimer's disease - current concepts
@en
prefLabel
Fluid biomarkers in Alzheimer's disease - current concepts
@en
P2860
P50
P356
P1476
Fluid biomarkers in Alzheimer's disease - current concepts
@en
P2093
Christoffer Rosén
P2860
P2888
P356
10.1186/1750-1326-8-20
P5008
P577
2013-06-21T00:00:00Z
P5875
P6179
1022388114